Severe colitis associated with both epstein-barr virus and cytomegalovirus reactivation in a patient with severe aplastic anemia

Case Reports in Gastroenterology

Volumn 8, Issue 2, 2014, Pages 240-244

  Matsumoto, Hiroshi ^a   Kimura, Yoshiki ^a   Murao, Takahisa ^a   Osawa, Motoyasu ^a   Akiyama, Takashi ^a   Mannoji, Kiyohito ^a   Koresawa, Risa ^a   Tokunaga, Hirotoshi ^a   Wada, Hideho ^a   Sugihara, Takashi ^a   Haruma, Ken ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Aplastic anemia; Colitis; Cytomegalovirus; Epstein Barr virus

Indexed keywords

GANCICLOVIR;

ADULT; APLASTIC ANEMIA; ARTICLE; BLOOD SAMPLING; BLOODY DIARRHEA; CASE REPORT; COLITIS; COLON; COLON BIOPSY; COLONOSCOPY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; EPSTEIN BARR VIRUS; FOLLOW UP; GASTROINTESTINAL TRACT; HUMAN; IN SITU HYBRIDIZATION; INFLAMMATORY BOWEL DISEASE; MALE; MIDDLE AGED; PRIORITY JOURNAL; VIRUS REACTIVATION;

EID: 84927589619     PISSN: None     EISSN: 16620631     Source Type: Journal    
DOI: 10.1159/000365546     Document Type: Article

References (12)

1. Cohen JI: Epstein-Barr virus infection. N Engl J Med 2000;343:481-492.
2. Luzuriaga K, Sullivan JL: Infectious mononucleosis. N Engl J Med 2010;362:1993-2000.
3. Galiatsatos P, Shrier I, Lamoureux E, Szilagyi A: Meta-Analysis of outcome of cytomegalovirus colitis in immunocompetent hosts. Dig Dis Sci 2005;50:609-616.
4. Scheinberg P, Fischer SH, Li L, Nunez O, Wu CO, Sloand EM, Cohen JI, Young NS, John Barrett A: Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood 2007;109:3219-3224.
5. Grinde B: Herpesvirus: latency and reactivation-viral strategies and host response. J Oral Microbiol 2013;25:5.
6. Sugimoto-Sekiguchi H, Tashiro H, Shirasaki R, Arai T, Yamamoto T, Oka Y, Akiyama N, Kawasugi K, Shirafuji N: Colonic EBV-Associated lymphoproliferative disorder in a patient treated with rabbit antithymocyte globulin for aplastic anemia. Case Rep Gastrointest Med 2012;2012:395801.
7. Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, Imai S, Ohga S, Kanegane H, Tsuchiya S, Morio T, Mori M, Yokota S, Imashuku S: Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 2005;80:64-69.
8. Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, Peh SC, Chan JK; CAEBV Study Group: Proposed categorization of pathological states of EBV-Associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int 2008;58:209-217.
9. Linton MS, Kroeker K, Fedorak D, Dieleman L, Fedorak RN: Prevalence of Epstein-Barr virus in a population of patients with inflammatory bowel disease: a prospective cohort study. Aliment Pharmacol Ther 2013;38: 1248-1254.
10. Ryan JL, Shen YJ, Morgan DR, Thorne LB, Kenney SC, Dominguez RL, Gulley ML: Epstein-Barr virus infection is common in inflamed gastrointestinal mucosa. Dig Dis Sci 2012;57:1887-1898.
11. Magro F, Santos-Antunes J, Albuquerque A, Vilas-Boas F, Macedo GN, Nazareth N, Lopes S, Sobrinho-Simões J, Teixeira S, Dias CC, Cabral J, Sarmento A, Macedo G: Epstein-Barr virus in inflammatory bowel disease-correlation with different therapeutic regimens. Inflamm Bowel Dis 2013;19:1710-1716.
12. Weinberg I, Neuman T, Margalit M, Ayman F, Wolf DG, Ben-Yehuda A: Epstein-Barr virus-related diarrhea or exacerbation of inflammatory bowel disease: diagnostic dilemma. J Clin Microbiol 2009;47:1588-1590.